CVE-2026-1031 — MEDIUM (6.1)

Vulnerability Description

IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

CVSS Score

6.1

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality

LOW

Integrity

LOW

Availability

NONE

Related Weaknesses (CWE)

CWE-79

References

https://www.ibm.com/support/pages/node/7286490

FAQ

What is CVE-2026-1031?

CVE-2026-1031 is a vulnerability with a CVSS score of 6.1 (MEDIUM). IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embe...

How severe is CVE-2026-1031?

CVE-2026-1031 has been rated MEDIUM with a CVSS base score of 6.1/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2026-1031?

Check the references section above for vendor advisories and patch information. Review vendor security bulletins for remediation guidance.